The Department of Medicine

Wahid T. Hanna, MD

Professor
Division of Hematology and Oncology

Clinical Focus

General Oncology, Thrombosis and Hemostasis

Education

Medical School
Ain-Shams University Hospital, Egypt, 1969

Residency
Registrar Hematology, St. Catherine's Hospital, England, 1975; Registrar Hematology, Walton Hospital, England, 1976

Fellowship
Senior Registrar Hematology, Liverpool Royal Infirmary, Liverpool University Hospital, England, 1977
Second Year Fellow in Hematology/Medical Oncology, University of Tennessee Medical Center, 1978
Special Fellow in Oncology, University of Tennessee Medical Center, 1979

Certifications

Diplomate of the International Board of Clinical and Applied Thrombosis, Hemostasis and Vascular Medicine

Professional Affiliations

World Federation of Hemophilia
International Society on Thrombosis and Hemostasis
Knoxville Academy of Medicine
Tennessee Medical Association
American Heart Association
Fellow Council on Arteriosclerosis
Thrombosis and Vascular Biology
Fellow, International Society of Hematology
American Medical Association
American Society of Hematology
International Society of Experimental Hematology
Southern Medical Association
New York Academy of Sciences, Founding Member
Hemophilia Research Society
American Society of Clinical Oncology
National Hemophilia Foundation
American Federation for Medical Research
Southern Association for Oncology
American Association for the Advancement of Science

Current Publications

Roman E, Fattizzo B, Shum MK, Hanna WT, Lentz SR, Araujo SSS, Al-Adhami M, Grossi FV, Gertz MA..
Safety and efficacy of pegcetacoplan treatment for cold agglutinin disease and warm antibody autoimmune hemolytic anemia. Blood. 2024 Nov 1:blood.2023022549. doi: 10.1182/blood.2023022549. Online ahead of print.

Barcellini W, Pane F, Patriarca A, Murakhovskaya I, Terriou L, DeSancho MT, Hanna WT, Leopold L, Rappold E, Szeto K, Wei S, Jäger U.
Parsaclisib for the treatment of primary autoimmune hemolytic anemia: Results from a phase 2, open-label study. Am J Hematol. 2024 Oct 22. doi: 10.1002/ajh.27493. Online ahead of print.

Borazanci EH, Bahary N, Chung V, Huyck TK, Kio EA, Chiorean EG, Skeel RT, Alese OB, Cardin DB, Fountzilas C, Hanna WT, Leal AD, Lee V, Noonan AM, Philip PA, Wainberg ZA, Pashova H, Mann G, Oberstein PE.
Relacorilant plus nab-paclitaxel for the treatment of metastatic pancreatic ductal adenocarcinoma: results from the open-label reliant study. Oncologist. 2024 Aug 26:oyae210. doi: 10.1093/oncolo/oyae210. Online ahead of print.